Ledger.Open graph →
SEC Form D · filed September 23, 2025

Prolifagen, Inc

Offering
—
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DOYLESTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Claudine Bruck · Berwyn, PAExec · DirectorM. A. Shaw · Doylestown, PADirectorAndreas A. Bader · Doylestown, PAExecWilliam A. Houston · Doylestown, PAExecMichael Behr · Doylestown, PAExec · DirectorM. A. Shaw · Doylestown, PADirectorAndreas A. Bader · Doylestown, PAExecWilliam A. Houston · Doylestown, PAExecMichael Behr · Doylestown, PAExec · DirectorClaudine Bruck · Berwyn, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗